GSK plc reports

Company location
London
GSK plc has filed 6,794 SEC EDGAR filings since 12 Jan 2001

SEC filing history

Showing 851-875 of 1,000 matching filings.

Per page
25
Current page
35
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
14 Feb 2023
Reporting date
14 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
14 Feb 2023
Reporting date
14 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
10 Feb 2023
Reporting date
10 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

JEMPERLI FULL FDA APPROVAL FOLLOWING GARNET TRIAL

Filing date
10 Feb 2023
Reporting date
10 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

JEMPERLI FDA ODAC POSITIVE OUTCOME

Filing date
10 Feb 2023
Reporting date
10 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SCHEDULE 13G

Filing date
06 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DAPRODUSTAT APPROVED BY US FDA FOR ANAEMIA OF CKD

Filing date
02 Feb 2023
Reporting date
02 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
01 Feb 2023
Reporting date
01 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TOTAL VOTING RIGHTS

Filing date
01 Feb 2023
Reporting date
01 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

BENLYSTA GRANTED ORPHAN DRUG DESIGNATION BY US FDA

Filing date
01 Feb 2023
Reporting date
01 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

FINAL RESULTS

Filing date
01 Feb 2023
Reporting date
01 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SCHEDULE 13G

Filing date
30 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-37627

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP

Filing date
30 Jan 2023
Reporting date
23 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

AMENDMENT TO FORM SC 13D

Filing date
20 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SCHEDULE 13D/A

Filing date
20 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
18 Jan 2023
Reporting date
18 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
17 Jan 2023
Reporting date
17 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
17 Jan 2023
Reporting date
17 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
13 Jan 2023
Reporting date
13 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
12 Jan 2023
Reporting date
12 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TOTAL VOTING RIGHTS

Filing date
03 Jan 2023
Reporting date
03 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
22 Dec 2022
Reporting date
22 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
21 Dec 2022
Reporting date
21 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
21 Dec 2022
Reporting date
21 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

BOARD AND COMMITTEE CHANGES

Filing date
15 Dec 2022
Reporting date
15 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .